Author: Upton Sinclair
Publisher:
ISBN:
Category : Chicago (Ill.)
Languages : en
Pages : 442
Book Description
California Pure Food and Drug Acts, with Rules and Regulations, Standards of Purity and Decisions Rendered by Secretary of Agriculture ...
Author: California
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 106
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 106
Book Description
California Pure Foods and Drugs Acts, Food Sanitation Act, Cold Storage Act
Author: California
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 164
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 164
Book Description
California pure food and drugs acts, and food sanitation act with rules and regulations, standards of purity and decisions rendered by Secretary of Agriculture ... 1916
Author: California
Publisher:
ISBN:
Category :
Languages : en
Pages : 178
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 178
Book Description
California pure food and drugs acts, and food sanitation act with rules and regulations, standards of purity and decisions rendered by Secretary of Agriculture ... 1909
Author: California
Publisher:
ISBN:
Category :
Languages : en
Pages : 104
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 104
Book Description
The Jungle
Author: Upton Sinclair
Publisher:
ISBN:
Category : Chicago (Ill.)
Languages : en
Pages : 442
Book Description
Publisher:
ISBN:
Category : Chicago (Ill.)
Languages : en
Pages : 442
Book Description
Federal, State, and Territorial Reference Manual of Pure Food and Drug Law
Author: Charles Wesley Dunn
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 2518
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 2518
Book Description
The Pharmaceutical Era
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 688
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 688
Book Description
A Legislative History of the Federal Food, Drug, and Cosmetic Act and Its Amendments
Author: United States
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 928
Book Description
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 928
Book Description
American Pure Food and Drug Laws
Author: James Westervelt
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1560
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1560
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.